Challenges and opportunities for cell line secretomes in cancer proteomics. Issue 3 (10th February 2015)

• Record Type: Journal Article
• Authors: Méndez, Olga; Villanueva, Josep
• Other Names: Banks Roz guestEditor.; Lilley Kathryn guestEditor.; Speicher David W. guestEditor.
• Is Part Of: Proteomics. Volume 9:Issue 3/4(2015)
• Page Start: 348
• Page End: 357
• Publication Date: 2015-02-10
• Subjects: Biomarker discovery -- Nonclassical secretion; Proteomics -- Periodicals; 572.605
• DOI: 10.1002/prca.201400131
• Languages: English
• ISSNs: 1862-8346

Abstract

Abstract : Cancer cell lines are the most widely used experimental models in cancer research. Their advantages of easy growth and manipulation are unfortunately paralleled by their limitations derived from long‐term growth in isolation from the rest of the tumor, and hence, lack of tumor microenvironment. We are however currently witnessing novel and transformative advances that are making cell lines more reflective of the human biology and therefore, better experimental models for cancer research. Beyond the experimental model used, the choice of cellular proteome is key in proteomics‐based biomarker discovery. Over the last decade, cell line secretomes have been proposed as an alternative for tumor biomarker discovery due to the difficulties posed by plasma in terms of complexity and low abundance of tumor‐specific biomarkers. Cell line secretomes are enriched with proteins already linked to tumorigenesis, which also have a good chance of being present in biological fluids. In this review, we will provide an overview of the main technical and biological issues related to cell line secretome analysis, and briefly discuss both the challenges and opportunities in its use for tumor biomarker discovery.